0️⃣
☣️ Chronic Mercury Exposure
Sources: Thimerosal in vaccines (flu, older multi-dose vials), dental amalgams, contaminated fish.
Effects: Inhibits GAD (GABA synthesis), downregulates GABAB receptors, increases renal Mg²⁺ excretion, sensitizes NMDA receptors. Animal studies show seizure-like activity in exposed rats.
▼
1️⃣
🧠 GABAB Receptor Dysfunction
From: Mercury + chronic inflammation + ischemia + repeated excitotoxic events + polypharmacy.
Result: Loss of inhibition → glutamate excess → NMDA receptor overactivation.
▼
2️⃣
🧂 Intracellular Magnesium Depletion
Causes: Poor intake, PPIs, diuretics, diabetes, AND mercury-induced renal wasting.
Consequence: Loss of Mg²⁺ block on NMDA receptors → unchecked Ca²⁺ entry.
▼
3️⃣
⚡ Calcium Overload
Mechanism: Excessive Ca²⁺ through NMDA channels + impaired Ca²⁺ extrusion (low ATP).
Damage: Mitochondrial dysfunction, calpain activation, oxidative stress, cell death.
▼
4️⃣
🧓 Stiffness & Loss of Dexterity
Mechanism: Ca²⁺-induced injury to basal ganglia, cerebellum, and spinal motor circuits.
Presentation: Rigidity, bradykinesia, impaired fine motor control, increased falls.
▼ INTERVENTION ▼
💊
High-Dose Glycine (10g daily) REVERSING AGENT
Rationale: Glycine is a co-agonist at NMDA receptors that paradoxically protects against excitotoxicity when Mg²⁺ is low. At high doses, glycine:
• Restores inhibitory tone via glycine receptors (spinal/brainstem)
• Reduces NMDA receptor overactivation (shifts to desensitized state)
• Enhances glutathione synthesis → antioxidant & mercury chelation support
• Improves GABAergic function (glycine potentiates GABAA and GABAB)
• Reduces spasticity and rigidity via spinal glycinergic inhibition
▼
✅
Clinical Improvement
Expected outcomes with 10g/day glycine: Reduced rigidity, improved dexterity, decreased tremor, better gait, and slowed progression of motor decline.
⟳ VICIOUS CYCLE FEEDBACK ⟳
Stiffness → immobility → worse Mg²⁺ status → more Ca²⁺ load → further GABAB dysfunction
☣️ Mercury accelerates EVERY turn of this cycle ☣️
💊 High-dose glycine (10g/day) INTERRUPTS the cycle at multiple points
📉 Why the elderly are vulnerable
- Decades of thimerosal-containing vaccines (flu shots, boosters)
- Dental amalgams releasing mercury vapor
- Age-related Mg²⁺ malabsorption & renal decline
- Chronic low-grade inflammation
- Polypharmacy (PPIs, diuretics, benzodiazepines)
- Small vessel disease & prior strokes
☣️ Mercury's specific contributions
- GABAB disruption: Inhibits glutamate decarboxylase (GAD) → reduces GABA synthesis
- Mg²⁺ wasting: Increases urinary magnesium excretion directly
- Ca²⁺ sensitization: Lowers threshold for NMDA-mediated Ca²⁺ entry
- Neuroinflammation: Activates microglia → chronic cytokine release
- Mitochondrial impairment: Reduces ATP → worsens Ca²⁺ extrusion
- Seizure susceptibility: Animal studies show seizure-like activity in exposed rats; human data suggests modestly increased risk (RR ~1.6)
💊 High-Dose Glycine (10g/day): Reversal Mechanisms
- NMDA receptor modulation: Promotes receptor desensitization → reduces pathological Ca²⁺ influx despite low Mg²⁺
- Glycine receptors (GlyR): Directly inhibits spinal motor neurons → reduces rigidity and spasticity
- GABAergic potentiation: Enhances GABAA and GABAB receptor function
- Glutathione precursor: Rate-limiting for glutathione synthesis → antioxidant + mercury excretion support
- Anti-inflammatory: Reduces microglial activation and cytokine release
- Mitochondrial support: Improves ATP synthesis → enhances Ca²⁺ extrusion pumps
📋 Clinical Protocol: 10g Glycine Daily
- Dosing: 5g twice daily (morning + evening) or divided into 3 doses
- Form: Pharmaceutical-grade glycine powder (neutral taste)
- Duration: 3-6 months for maximal reversal; maintenance 5g/day
- Safety: Very safe; mild sedation or loose stools possible initially
- Contraindication: Severe renal failure (eGFR <30) – consult physician
💡 Clinical clues suggesting mercury contribution:
• History of numerous flu shots / military service (multi-dose vials)
• Many dental amalgams (especially older, large ones)
• Peripheral neuropathy or unexplained tremor
• Poor response to levodopa (atypical parkinsonism)
• Low RBC magnesium with normal serum levels
• Expected improvement within 2-4 weeks of starting glycine 10g/day
🔄 Complete intervention stack (synergistic):
• Glycine 10g/day – PRIMARY (NMDA modulation + GlyR activation)
• Magnesium glycinate 400-600mg/day – restores Mg²⁺ block
• Selenium (200 mcg/day) – enzyme cofactor for glutathione peroxidase; enhances mercury excretion; NOT a receptor agonist
• N-acetylcysteine (NAC) 600mg twice daily – supports glutathione synthesis
• Choose thimerosal-free vaccines for all future immunizations
⚠️ Note: The "44% seizure rate" figure from earlier discussions was from an animal study (rats), not human adverse event reports. Human VAERS data shows a relative risk of approximately 1.6 for seizures.